Pharmaceutical

AGC Biologics and Quell to progress Treg cell therapy development

AGC Biologics has collaborated with Quell Therapeutics to advance the development of several T-regulatory (Treg) cell therapy drugs.

May 18, 2025 - 06:00
AGC Biologics and Quell to progress Treg cell therapy development
AGC Biologics has collaborated with Quell Therapeutics to advance the development of several T-regulatory (Treg) cell therapy drugs.
Read the original article

Tags:

Previous Article

FDA biosimilar approvals set for record-breaking year amid US pricing reforms

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

A half century after Prozac, a new generation of depression drugs is bringing hope to a long-stagnant field

A half century after Prozac, a new generation of depres...

Mar 28, 2023

STAT+: Brigham and Women’s exec opens up about the Dana-Farber Cancer Institute split, and what it means for the future of cancer care

STAT+: Brigham and Women’s exec opens up about the Dana...

Sep 28, 2023

PXS-4728 by Syntara for Sleep Disorders: Likelihood of ...

Jan 25, 2024